Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology

Immune checkpoint inhibitors (ICIs) are monoclonal antibody antagonists, which can block cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1/ligand-1 (PD-1/PD-L1) pathways, and other molecules exploited by tumor cells to evade T cell-mediated immune response. ICIs have transformed the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yingying, Yu, Hui, Dai, Shuang, He, Miao, Ma, Ling, Xu, Zihan, Luo, Feng, Wang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491874/
https://www.ncbi.nlm.nih.gov/pubmed/37692505
http://dx.doi.org/10.1016/j.gendis.2023.01.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491874/
https://www.ncbi.nlm.nih.gov/pubmed/37692505
http://dx.doi.org/10.1016/j.gendis.2023.01.024

Ejemplares similares